Clinical trial
Hemostatic Matrix in Endoscopic Sinus Surgery
NCT00242437 · Ethicon, Inc., Industry · Completed
Key facts
| NCT number | NCT00242437 |
|---|---|
| Title | Hemostatic Matrix in Endoscopic Sinus Surgery |
| Official title | A Prospective, Multicenter Study to Evaluate Hemostatic Matrix With Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Endoscopic Sinus Surgery |
| Lead sponsor | Ethicon, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sinusitis |
| Intervention type | Device |
| Interventions | Hemostatic matrix, bovine thrombin |
| Enrollment | 30 |
| Start date | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Oct 20, 2005 |
| Last update posted | Jul 13, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: